{"id":"W4230554561","doi":"10.1016/j.jval.2021.04.823","title":"PND39 Socioeconomic Value of Ocrelizumab in the Treatment of Patients with Relapsing Remitting Multiple Sclerosis","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Ocrelizumab; Medicine; Expanded Disability Status Scale; Teriflunomide; Cladribine; Multiple sclerosis; Socioeconomic status; Family medicine; Internal medicine; Environmental health; Population; Psychiatry; Fingolimod","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001968484,0.0001790152,0.0005174113,0.0004861317,0.0002727346,0.0008606112,0.000215167,0.0003671747,0.002839996],"category_scores_gemma":[0.01292941,0.00007715022,0.0009207267,0.000740229,0.0002496335,0.0005369001,0.0007440591,0.0009966381,0.0001287308],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001674776,"about_ca_system_score_gemma":0.0009929725,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004677363,"about_ca_topic_score_gemma":0.004872164,"domain_scores_codex":[0.9983674,0.001065092,0.0001129696,0.00005899918,0.0002570312,0.0001384962],"domain_scores_gemma":[0.9961985,0.001809412,0.0009875568,0.000117611,0.0003079248,0.0005790192],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0245692,0.001509214,0.6960143,0.0009889418,0.003517014,0.0005242042,0.0002690577,0.009243661,0.0004502481,0.006076021,0.007189529,0.2496486],"study_design_scores_gemma":[0.001673461,0.00526139,0.9593989,0.0007328664,0.001644705,0.000604926,0.0005675645,0.01560172,0.0003533282,0.006010983,0.00809279,0.00005729995],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9718658,0.009364435,0.0002519448,0.006219234,0.000163282,0.00004593185,0.002441618,0.000007379316,0.0096404],"genre_scores_gemma":[0.9988231,0.0005155702,0.00007375725,0.00009397804,0.00004130015,0.000007684399,0.0003204669,8.715352e-7,0.0001232173],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004677363,"threshold_uncertainty_score":0.01215136,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3144445585958653,"score_gpt":0.3669548117396245,"score_spread":0.05251025314375918,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}